Watching for something good to maybe come out of this? October 16th to 18th!
$Verastem (VSTM.US)$Verastem Oncology Announces Details for the Oral Presentation of the Mature Ramp 201 Data Evaluating Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer at the Igcs 2024 Annual Meeting
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more